Skip to main content
Smart Investors Daily
OS

OTC · OSSUY

Embla Medical hf.

Healthcare · Medical - Devices

$4.23

Up+$0.00 (+0.00%)

Updated Nov 4, 2026, 8:56 PM

SID Score

4.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.37B
P/E ratio
30.46
Dividend yield
0.00%
52-week range
— – —
Volume
1K
Avg. volume
17

Price performance · OSSUY

OSSUY price history

1M range · 0 trading sessions · Daily adjusted prices

OSSUY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest OSSUY news

The latest Smart Investors Daily articles mentioning OSSUY.

OSSUY research

Overview

Company profile and research snapshot.

Company profile

EMBLA MEDICAL HF S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
OSSUY recent ratings
DateFirmRatingTarget
Sep 21, 2026BERENBERGBuy—
Jul 22, 2026DNB CARNEGIEHold—
Jul 14, 2026DNB CARNEGIEHold—
Jul 13, 2026DNB CARNEGIEHold—
Jun 3, 2026BERENBERGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 21, 2026

Embla Medical (CPSE:EMBLA) Stock Faces Q3 Results And Softer Growth Outlook

Embla Medical hf walked into its Q3 2026 release with the share price down over the past week, month and quarter, even as the stock traded on a trailing P/E of 17.7x, well below European medical equipment peers. The fresh numbers show Q3 revenue of US$249.6m and net profit of US$26.1m, with an EBITDA margin of 22% holding steady against last year. That mix, solid profitability but trimmed full year organic growth guidance to about 5%, sets up a sentiment clash between a cautious tape and a...

Yahoo · Oct 8, 2026

Embla Medical hf (CPSE:EMBLA), Why Is Attention Building Around It Today?

Recent Trading Snapshot and Business Context Embla Medical hf (CPSE:EMBLA) closed at DKK 27.65 on 7 October 2026, leaving the share down over the year but with mixed shorter term moves across the past week, month and past 3 months. Recent action around Embla Medical hf has been choppy, with a 7-day share price return of 4.93% and a 90-day gain of 5.33%. This is set against a year-to-date share price decline of 13.59% and a 5-year total shareholder return down 36.44%, which points to...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.